Figures computed from official regulatory filings — .
Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
SCOLR Pharma, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
SCOLR Pharma, Inc.Listing unverified | AwardD (derivative) | $93.5K | SEC | ||
SCOLR Pharma, Inc.Listing unverified | Buy | $2.7K | conv 41Cluster | SEC | |
SCOLR Pharma, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
SCOLR Pharma, Inc.Listing unverified | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
SCOLR Pharma, Inc.Listing unverified | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
SCOLR Pharma, Inc.Listing unverified | Buy | $3.1K | conv 44Cluster | SEC | |
SCOLR Pharma, Inc.Listing unverified | Buy | $1.3K | conv 59Cluster | SEC | |
SCOLR Pharma, Inc.Listing unverified | Buy | $499.2 | conv 54Cluster | SEC | |
SCOLR Pharma, Inc.Listing unverified | Buy | $4K | conv 84Cluster | SEC | |
SCOLR Pharma, Inc.Listing unverified | Buy | $763.8 | conv 34Cluster | SEC | |
SCOLR Pharma, Inc.Listing unverified | Buy | $6K | conv 89ClusterFirst in 12mo | SEC | |
SCOLR Pharma, Inc.Listing unverified | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
SCOLR Pharma, Inc.Listing unverified | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |